ArticleJournal of cardiovascular electrophysiology2026
Left Atrial Posterior Wall Functional Remodeling in Paroxysmal and Persistent Atrial Fibrillation. A Pilot Study.
Article in Journal of cardiovascular electrophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThe left atrial posterior wall (LAPW) is often targeted in atrial fibrillation (AF) ablation due to its shared properties with pulmonary veins. However, substrate-guided approaches using structural markers have shown inconsistent results. We investigated posterior wall conduction time (PWCT) as a novel and functional marker of LAPW remodeling in AF patients.
methodsIn our pilot study, 40 patients undergoing first-time AF ablation (20 paroxysmal, 20 persistent AF) were included. AF cycle length (AF CL), PW linear conduction, PW conduction area (PWCA) and PWCT were evaluated on electroanatomical mapping at different pacing CLs. Major decremental PWCT was defined as PWCT increase ≥ 17% at 400 ms compared to 600 ms.
resultsPersistent AF patients had a larger posterior wall area (PWA; 20.4 ± 5.2 vs. 16.8 ± 4.9 cm², p = 0.033), greater low voltage area (LVA; 16.5 ± 25.8% vs. 6.1 ± 19.8%, p = 0.044) and shorter left atrial appendage AF CLs (shortest AF CL 146.2 ± 36.3 vs. 179.1 ± 37.1 ms, p = 0.012) than paroxysmal AF patients. PWCT was numerically longer in persistent AF, with major ΔPWCT observed exclusively in 6 persistent AF patients. In this subgroup, PWCA was reduced at each 10 ms increment during 400 ms pacing, a finding not observed in non-major ΔPWCT subgroup. Major ΔPWCT did not correlate with PWA size, LVA, or AF CL.
conclusionPWCT may represent a novel functional biomarker of LAPW remodeling, independent of structural changes, potentially identifying patients who may benefit from targeted LAPW ablation. Further studies are needed to validate PWCT as a guide for personalized AF ablation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.